|
⚲
|
| Oraya Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001395387 |
| Sale | 2009-07-17 ($20.9 M Offered, $20.9 M Sold) |
| Fund | |
| Phone | 5104563702 |
| Address | 8000 Jarvis Avenue Newark, 94560 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Brian Halak | |
| Reza Zadno | |
| Michael Gertner | |
| John Onopchenko | |
| Guido Neels | |
| Mark Brooks | |
| Peter Cohn |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Murray Mark A
✚
|
0.0 | |
|
Murray Scott E.
✚
|
0.0 | |
|
Muse Nashville, LLC
✚
|
0.0 | |
|
Muse Scott H
✚
|
0.0 | |
|
Mushakov Andrey
✚
|
0.0 | |
|
Muskogee Multifamily Investors I, LP
✚
|
0.0 | |
|
Muskrat Daniel J.
✚
|
0.0 | |
|
Musmanno Thomas
✚
|
0.0 | |
|
Musser William L
✚
|
0.0 | |
|
Murray George C
✚
|
0.0 |